ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,710, issued on June 10, was assigned to The Regents of the University of California (Oakland, Calif.).
"Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-bindoles for treating brain disorders" was invented by David E. Olson (Davis, Calif.) and Florence F. Wagner (Davis, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides azepino-indoles and other heterocycles and methods of using the compounds for treating brain disorders. The present invention provides a compound of Formula (Ia), or a pharmaceutically acceptable salt or isomers thereof, wherein the compound has the following structure:"
The patent was filed on July 12, ...